Universitätsklinikum Hamburg-Eppendorf (UKE)

Impact on follow-up strategies in patients with primary sclerosing cholangitis (2022) Bergquist A, Weismueller TJ, Levy C, Rupp C, Joshi D, Nayagam JS, Montano-Loza AJ, et al. Journal article Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial (2022) Ferreri AJM, Cwynarski K, Pulczynski E, Fox CP, Schorb E, Celico C, Falautano M, et al. Journal article Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes (2022) Lampe L, Niehaus S, Huppertz HJ, Merola A, Reinelt J, Mueller K, Anderl-Straub S, et al. Journal article Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy (2022) Aypek H, Krisp C, Lu S, Liu S, Kylies D, Kretz O, Wu G, et al. Journal article LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma (2022) Mateos MV, Weisel K, De Stefano V, Goldschmidt H, Delforge M, Mohty M, Cavo M, et al. Journal article Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT (2022) Machowicz R, Suarez F, Wiktor-Jedrzejczak W, Eikema DJ, De Wreede LC, Blok HJ, Isaksson C, et al. Journal article Altered activation of the immune response causes radioresistance in HR-impaired breast cancer cells (2022) Classen S, Rahlf E, Jungwirth J, Poole L, Gehre S, Rückert M, Petersen C, et al. Conference contribution 5. Ringversuch Arzneimittelinformation der ADKA. Was ist wichtig bei der Bearbeitung von Anfragen zu Nebenwirkungen? (2022) Strobach D, Chiriac U, Klausner S, Krebs S, Langebrake C, Querbach C, Schuhmacher C Journal article Ovarian function in young patients (pts) treated with postneoadjuvant palbociclib (PAL) and endocrine therapy (ET) for hormone receptor (HR)-positive, HER2-negative early breast cancer (BC): Explorative analysis in Penelope-B (2022) Furlanetto J, Marme F, Thode C, Nekljudova V, Liu Y, Jimenez MM, Reimer T, et al. Conference contribution Intermediate biopsies during neoadjuvant chemotherapy for breast cancer to predict patient outcome (2022) Sinn BV, Untch M, Karn T, Van Mackelenbergh M, Huober J, Sychra K, Schmitt WD, et al. Conference contribution